If small-company stocks offer the chance to get into businesses on the ground floor, and big blue chips offer world-beating stability, what do shares of midsize companies bring to the table? Historically, superior returns. Since 1980, the Russell Midcap index, which tracks U.S. stocks with $934 million to $34 billion in market capitalization (stock price times shares outstanding), returned 12.9% per year, on averageahead of the large-cap Standard & Poors 500-stock index (11.7%) and the small-cap Russell 2000 index (11%).
See Also: Mid-Cap Stocks Are the Market’s Sweet Spot
Patrick Dunkerley, who comanages the Scout Mid Cap Fund (UMBMX), describes mid caps as a market sweet spot, offering more stability than small companies (thanks to, among other things, more-seasoned executives) and better growth potential than large firms. The fund, which holds 142 stocks, aims to eclipse the long-term performance of the Russell Midcap index.
Best Blue Chip Stocks To Buy For 2018: Allied Motion Technologies, Inc.(AMOT)
- [By Jim Robertson]
On Friday, our Under the Radar Moversnewsletter suggestedsmall cap precision and specialty motion control stock Allied Motion Technologies (NASDAQ: AMOT) as a possible long position:
Best Blue Chip Stocks To Buy For 2018: Majesco Entertainment Company(COOL)
- [By Lee Jackson]
These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).
Best Blue Chip Stocks To Buy For 2018: Coupa Software Incorporated (COUP)
- [By Taylor Cox]
Coupa Software Incorporated (NASDAQ: COUP)
Equifax Inc (NYSE: EFX) in New York
Annual Shareholder Meetings
1-800-Flowers.com, Inc (NASDAQ: FLWS)
Cicso Systems, Inc (NASDAQ: CSCO)
Best Blue Chip Stocks To Buy For 2018: Theravance Biopharma, Inc.(TBPH)
- [By WWW.KIPLINGER.COM]
The exact date Theravance Biopharma Inc. (TBPH) intends to release a phase 3 update on COPD treatment Revefenacin isnt known. The company simply said in a prior communication with the market it would be sharing an interim look at the trials progress sometime in early Q4.
Best Blue Chip Stocks To Buy For 2018: Catalyst Pharmaceuticals, Inc.(CPRX)
- [By Lisa Levin]
Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) got a boost, shooting up 32 percent to $1.54 after the company reported positive data from investigator-sponsored trial of Firdapse.
- [By William Romov]
Before we show you our pick, here are the top 10 penny stocks to watch this week
Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%
FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free